Dr. Harari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-8500Fax+1 608-263-9167
Education & Training
University of Arizona College of Medicine-TucsonResidency, Radiation Oncology, 1986 - 1990
University of California Davis HealthInternship, Internal Medicine, 1984 - 1985
University of Virginia School of MedicineClass of 1984
Certifications & Licensure
AZ State Medical License 1986 - Present
WI State Medical License 1990 - 2025
IL State Medical License 1994 - 2023- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
Clinical Trials
- Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Start of enrollment: 2004 Apr 01
- TRIAD Burden of Illness Mucositis Study Start of enrollment: 2005 Nov 01
- Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Start of enrollment: 2004 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 3567 citationsRadiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckJames A. Bonner, Paul M. Harari, Jordi Giralt, Nozar Azarnia, Dong M. Shin
The New England Journal of Medicine. 2006-02-09 - 78 citationsRadiation response modification following molecular inhibition of epidermal growth factor receptor signaling.Paul M. Harari, Shyhmin Huang
Seminars in Radiation Oncology. 2001-10-01 - 423 citationsMechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.Deric L. Wheeler, Shyhmin Huang, Tim J. Kruser, Meghan M. Nechrebecki, Eric A. Armstrong
Oncogene. 2008-06-26
Press Mentions
Society's Gold Medal Awarded to Trailblazing TrioSeptember 16th, 2024- UW Health to Be 1st to Offer Upright Proton Beam Cancer TherapyMay 18th, 2022
- New UW Health Facility Set to House Innovative Cancer Radiation TherapyMay 17th, 2022
- Join now to see all
Grant Support
- Egfr/Radiation Response And Resistance InteractionsNational Cancer Institute2006–2010
- Egfr/Radiation Responses And Resistance InteractionsNational Cancer Institute2007–2009
- Surgery Followed By Chemoradiotherapy + C225 For Head And Neck CarcinomaNational Center For Research Resources2006–2007
- Conformal Avoidance Tomotherapy For Head And Neck CancerNational Cancer Institute2001–2002
- Radiation Therapy &Comcomitant C225 In Head/Neck SCCNational Center For Research Resources2000
- Polyamine Modulation Of Squamous Cancer Growth KineticsNational Cancer Institute1995–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
